GRIP Molecular Technologies
Saint Paul · Founded 2019
About GRIP Molecular Technologies
GRIP Molecular Technologies is a molecular detection device used at point-of-care to enable the rapid identification of chemical and biological threats. The Minnesota-based molecular diagnostics company is developing a proprietary and patented electronic biosensor that can detect a wide range of biomarkers in a single test.
Company Facts
- Founded: 2019
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: Less than $1M
- Total funding: $50.0K
- Last round: Non-Equity Assistance (Oct 2020)
- Website: https://www.gripmolecular.com/
- Phone: 612-669-9320
Industries & Categories
Biotechnology, Life Science, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/grip-molecular-technologies-156295 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.